Analysis of the effectiveness of premedication in preventing early adverse reactions to antivenom serum from 2017 to 2021: A cohort study
Open Access
- 1 January 2025
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 61, e23833
Abstract
This study aimed to analyze the effectiveness of using an antivenom serum (AVS) premedication protocol to prevent early adverse reactions (EAR). This is a cohort study conducted with data from the Londrina Information and Toxicological Assistance Center (CIATox-Londrina) at the University Hospital of the State University of Londrina (HU-UEL), which included patients treated with AVS between January/2017 and December/2021. The independent variable was performing the premedication protocol and the dependent variable was the occurrence of EAR after AVS administration. Patients were followed until hospital discharge. The association analysis was performed with calculation of the Relative Risk (RR) and 95% Confidence Interval (95% CI). A total of 806 cases of accidents with venomous animals were analyzed. The minority (8.1%; n=65) had EAR, and the most frequent symptoms were related to dermatological and respiratory manifestations. The AVS premedication protocol was performed in 96.6% (n=734) of the cases. There was no statistically significant difference in the unadjusted (RR: 1.487; 95% CI: 0.530-4.174) and adjusted (RR: 1.482; 95% CI: 0.522-4.210) models regarding the performance of the AVS premedication protocol and the occurrence of EAR. It is recommended against AVS premedication given the lack of effectiveness in preventing EAR.Keywords
This publication has 13 references indexed in Scilit:
- Current research into snake antivenoms, their mechanisms of action and applicationsBiochemical Society Transactions, 2020
- Clinical studies of the effectiveness and safety of antivenomsToxicon, 2018
- Pros and cons of different therapeutic antibody formats for recombinant antivenom developmentToxicon, 2018
- Antivenom therapy: efficacy of premedication for the prevention of adverse reactionsJournal of Venomous Animals and Toxins including Tropical Diseases, 2018
- Adverse reactions to snake antivenom, and their prevention and treatmentBritish Journal of Clinical Pharmacology, 2015
- A Randomised Controlled Trial of Two Infusion Rates to Decrease Reactions to AntivenomPLOS ONE, 2012
- Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab′)2] antivenoms, in Bothrops asper bites in ColombiaToxicon, 2012
- Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled TrialPLOS Medicine, 2011
- Snake AntivenomsJournal of Toxicology: Clinical Toxicology, 2003
- Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bitesBMJ, 1999